Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 279

The DOI matches its Crossref record.

Somatic mutations in the RET proto‐oncogene in sporadic medullary thyroid carcinoma

Marsh, Debbie J., Learoyd, Diana L., Andrew, Scott D., Krishnan, Lalitha, Pojer, Ruth, Richardson, Anne‐Louise, Delbridge, Leigh, Eng, Charis, Robinson, Bruce G.·1996·Clinical Endocrinology

Abstract

OBJECTIVE We have determined the frequency of specific mutations in the RET proto‐oncogene in sporadic medullary thyroid carcinomas (MTCs) and correlated the presence or absence of a codon 918 mutation with the clinical characteristics of these tumours. DESIGN Thirty paraffin‐embedded sporadic MTCs and two frozen MTCs were collected for analysis of specific mutations in the RET proto‐oncogene in codons 609, 611, 618 and 620 (exon 10); 630 and 634 (exon 11); 768 (exon 13); 883 (exon 15) and 918 (exon 16). A novel primer was designed which introduced a restriction site for Rsa I in the presence of the specific codon 918 mutation (ATG → ACG) in these tumour samples. A ‘clinical‐genetic’ correlation was performed comparing the presence or absence of the codon 918 mutation with the following clinical characteristics: age at diagnosis, tumour size, presence or absence of metastases, MTC related morbidity, and base line calcitonin levels at diagnosis or most recent follow‐up. PATIENTS Patients were classified as having sporadic MTC if there was no family history of C‐cell hyperplasia, MTC, phaeochromocytoma or parathyroid disease. Retrospective review of patient records enabled complete clinical data to be obtained in 28 of 32 patients. MEASUREMENTS Base line calcitonin levels were measured by radioimmunoassay or calcitonin enzyme linked immunoassay. Cysteine codons in exons 10 and 11, specifically codons 609, 611, 618, 620, 630 and 634, were screened for the presence of mutations by sequence analysis. Specific mutations occurring at codons 768, 883 and 918 were screened for by restriction endonuclease digestion of PCR products. RESULTS The mutation at codon 918ATG → ACG was found in 21 of 32 (66%) MTCs and the mutation at codon 883GCT → TTT was found in one of 32 MTCs. Where possible, the presence of ‘germline‐type’ mutations in codons 609, 611, 618, 620, 630 and 634 were excluded. Ten MTCs did not have a mutation in codons 768, 883 or 918 of the RET proto‐oncogene. The presence or absence of the somatic mutation at codon 918 did not correlate with any of the above clinical characteristics. CONCLUSION Somatic mutations in the RET proto‐oncogene occur frequently in sporadic MTCs.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1046/j.1365-2265.1996.681503.x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

See all 279

Metadata

Authors
Marsh, D. J., Learoyd, D. L., Andrew, S. D., Krishnan, L., Pojer, R., Richardson, A., Delbridge, L., Eng, C., & Robinson, B. G.
Venue
Clinical Endocrinology
Publisher
Wiley
Published
1996-03
Volume
44
Issue
3
Pages
249-257
ISSN
  • 0300-0664 (ISSN-L)
  • 1365-2265
OpenAlex
W2147994473
Cited by
279
References
0
FWCI
12.65
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Somatic mutations in the RET proto‐oncogene in sporadic medullary thyroid carcinoma. https://app.cochat.ai/papers/10.1046/j.1365-2265.1996.681503.x
The paper
Marsh, D. J., Learoyd, D. L., Andrew, S. D., Krishnan, L., Pojer, R., Richardson, A., Delbridge, L., Eng, C., & Robinson, B. G. (1996). Somatic mutations in the RET proto‐oncogene in sporadic medullary thyroid carcinoma. Clinical Endocrinology. https://doi.org/10.1046/j.1365-2265.1996.681503.x

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.